foxo4-dri senolytic peptide mouse model 2024 regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI - Wikipedia
FOXO4 DRI Wikipedia The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment npj Aging Full article: Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry
Pay in 4 interest-free payments of $6.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28



